Identité

Drospirenone Impurity 18

Non indiqué · C24H34O4

01Identité

Lazychem IDLC-39334
CAS RNNon indiqué
PubChem CID60002790
Molecular formulaC24H34O4
Molecular weight386.5 g/mol
IUPAC name(2R,4R,5R,7S,10R,14S,15S,16S,18S)-5,7-dihydroxy-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-15,5'-oxolane]-2'-one
InChIKeyJZWBUSOXVHJXDL-NTGCVWCASA-N

02Structure et stéréochimie

Two-dimensional chemical structure of Drospirenone Impurity 18
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 7 rings, includes aliphatic carbon, has 9 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres9
Ring count7
Secondary amines0
Tertiary amines0
SMILESC[C@]12CC[C@@H](C[C@]1([C@@H]3C[C@@H]3C4C2CC[C@]5(C4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C)O)O
InChINon indiqué

03Stereochemistry

The published structure contains 9 defined and 3 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres9Structure assigned
Unassigned centres3Structure unspecified
Assignment statusPartially assignedExact published identity
Tetrahedral upper bound≤ 4,096Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Statut en Inde

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Noms et relations

API et médicament parent

Non indiqué

Noms et relations

    06Sources